![]() |
市場調査レポート
商品コード
1656911
胎児・新生児ケア機器の世界市場 - 市場考察、競合情勢、市場予測(2032年)Fetal & Neonatal Care Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
||||||
カスタマイズ可能
適宜更新あり
|
胎児・新生児ケア機器の世界市場 - 市場考察、競合情勢、市場予測(2032年) |
出版日: 2025年01月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の胎児・新生児ケア機器の市場規模は、2024年に82億7,638万米ドルであり、2032年までに156億1,687万米ドルに達すると予測され、2025年~2032年の予測期間にCAGRで8.33%の成長が見込まれます。胎児・新生児ケア機器の需要は、世界の早産件数の増加によって大きく促進されています。これに加えて、先天異常や先天性欠損症の有病率の増加、技術の継続的な進歩が市場の成長を促進しています。さらに、主要企業による継続的な製品開発と頻繁な市場投入が、胎児・新生児ケア機器市場の拡大にさらに寄与しています。これらの要因は、2025年~2032年の予測期間に市場の前向きな成長軌道を形成する上で極めて重要な役割を果たすと予測されます。
胎児・新生児ケア機器の市場力学
早産の発生率の上昇は、胎児・新生児ケア機器市場の成長の主な促進要因です。UNICEF(2023)によると、世界では毎年約1,500万人、約10人に1人の赤ちゃんが早産で生まれています。
同様に、BLISS UK(2024)は、年間1,300万人を超える早産を報告しており、サブサハラアフリカと南アジアでもっとも高い有病率が観測されています。英国だけでも、毎年約5万8,000人の早産が発生しています。
オーストラリアでは、Northern Health Australia(2023)のデータによると、12人に1人が早産であり、アボリジニの赤ちゃんではその割合が15%とほぼ倍増し、年間2万6,000人以上が早産です。同様にカナダでも、Statistique Canada(2024)によると、全出生の8.3%、つまり年間約2万5,000人の赤ちゃんが早産です。この増加傾向は他の地域でも同様で、先進の胎児・新生児ケア機器に対する旺盛な需要を生み出しています。
これらの機器は、胎児の発育異常、子宮頸管の短縮、その他の母体や胎児の合併症など、早産に関連する危険因子を検出する上で極めて重要です。早期発見により、子宮収縮や胎児苦痛のモニタリングなど、タイムリーな介入が可能となり、早産のリスクを大幅に低減し、新生児の転帰を改善することができます。
先天異常や先天性欠損症の有病率の増加は、胎児・新生児ケア機器の市場成長を大きく促進しています。2023年3月の世界保健機関(WHO)のデータによると、世界全体で毎年推定800万人の新生児が先天異常を持って生まれています。憂慮すべきことに、重篤な先天性欠損症で生まれる子供の10人中9人は低中所得国であり、これらの地域における出生前ケアと診断ツールの改善が決定的に必要であることを浮き彫りにしています。胎児ケア機器、特に超音波診断システムは、先天異常の早期発見において極めて重要な役割を果たしています。超音波検査は、その高解像度の画像処理能力により、口唇口蓋裂、心臓欠陥、二分脊椎、水頭症、四肢奇形など、幅広い胎児疾患の同定が可能です。先天異常の有病率が伸び続ける中、先進の胎児ケア機器に対する需要は拡大し、市場の拡大をさらに加速させると予測されます。
このような早産や先天異常の症例の増加が、主要企業の先進機器開発を促進しています。例えば2024年9月、Samsungは産婦人科向けに設計された先進の超音波診断システム「HERA Z20」を発売しました。このシステムは最先端のAI診断支援を強化し、女性と胎児ともに健康状態を向上させます。リアルタイムの胎児イメージングを提供し、胎児の脳の3つの横断ビューから6つの測定値を提供し、よりよい出生前ケアに向け包括的な見識を提供します。
同様に2024年2月、GE HealthCareは米国食品医薬品局(FDA)からNovii(TM)+ Wireless Patch Solutionの510(k)認可を取得しました。この先進の母体・胎児モニタリングシステムは、胎児の心拍数、母体の心拍数、子宮活動などの重要なデータを非侵襲的に測定し、リアルタイムで表示します。Novii(TM)+ Wireless Patch Solutionは、継続的なリアルタイムの見識を提供することで、ケアチームが分娩前および分娩中の母体と胎児の健康状態を注意深くモニターすることを可能にします。
しかし、胎児・新生児ケア機器に関連する制限や院内感染の可能性などが、市場の成長を制限する可能性のある主な抑制要因となっています。
当レポートでは、世界の胎児・新生児ケア機器市場について調査分析し、各地域の市場規模と予測、過去3年の製品/技術開発、市場の主要企業、将来の機会などの情報を提供しています。
Fetal & Neonatal Care Equipment Market by Product Type (Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others}), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increase in number of preterm births and technological advancements in product development
The fetal & neonatal care equipment market was valued at USD 8,276.38 million in 2024, growing at a CAGR of 8.33% during the forecast period from 2025 to 2032 to reach USD 15,616.87 million by 2032. The demand for fetal and neonatal care equipment is being significantly driven by the rising number of preterm births globally. In addition to this, the increasing prevalence of congenital anomalies and birth defects, along with continuous advancements in technology, are fueling the growth of the market. Moreover, the ongoing product developments and frequent launches by leading market players are further contributing to the expansion of the fetal and neonatal care equipment market. These factors are expected to play a pivotal role in shaping the market's positive growth trajectory during the forecast period from 2025 to 2032.
Fetal & Neonatal Care Equipment Market Dynamics:
The rising incidence of preterm births is a major driver for the growth of the fetal and neonatal care equipment market. According to UNICEF (2023), approximately 15 million babies, about one in ten are born prematurely each year worldwide.
Similarly, BLISS UK (2024) reported over 13 million preterm births annually, with the highest prevalence observed in sub-Saharan Africa and Southern Asia. The United Kingdom alone accounts for around 58,000 premature births each year.
In Australia, data from Northern Health Australia (2023) reveals that one in 12 babies is born prematurely, with the rate nearly doubling to 15% for Aboriginal babies, amounting to over 26,000 preterm births annually. Similarly, in Canada, Statistique Canada (2024) indicates that 8.3% of all births, or approximately 25,000 babies annually, are preterm. This rising trend is mirrored in other regions, creating a robust demand for advanced fetal and neonatal care equipment.
These devices are crucial in detecting risk factors associated with preterm births, such as abnormal fetal growth, shortened cervix, and other maternal or fetal complications. Early identification enables timely interventions, including the monitoring of uterine contractions and fetal distress, which can significantly reduce the risk of premature delivery and improve neonatal outcomes.
The growing prevalence of congenital anomalies and birth defects is significantly driving the market growth for fetal and neonatal care equipment. According to data from the World Health Organization (WHO) in March 2023, an estimated 8 million newborns are born with a birth defect globally each year. Alarmingly, nine out of every ten children born with serious birth defects are in low- and middle-income countries, highlighting a critical need for improved prenatal care and diagnostic tools in these regions. Fetal care devices, particularly ultrasound systems, play a pivotal role in the early detection of congenital anomalies. Ultrasound, with its high-resolution imaging capabilities, enables the identification of a wide range of fetal conditions, including cleft lip and palate, heart defects, spina bifida, hydrocephalus, and limb malformations. As the prevalence of congenital anomalies continues to rise, the demand for advanced fetal care equipment is expected to grow, further accelerating the market expansion.
Such increasing cases of preterm births and congenital anomalies is promoting key players to develop advanced devices. For instance, in September 2024, Samsung launched the HERA Z20, an advanced ultrasound system designed for OB&GYN applications. The system enhances cutting-edge AI diagnostic assistance to improve the health of both women and fetuses. It provides real-time fetal imaging and delivers six measurements from three transverse views of the fetal brain, offering comprehensive insights for better prenatal care.
Similarly, in February 2024, GE HealthCare received 510(k) clearance from the United States Food and Drug Administration (FDA) for the Novii(TM)+ Wireless Patch Solution. This advanced maternal and fetal monitoring system offers noninvasive measurement and real-time display of critical data, including fetal heart rate, maternal heart rate, and uterine activity. By providing continuous, real-time insights, the Novii(TM)+ Wireless Patch Solution enables care teams to closely monitor both maternal and fetal health during antepartum and intrapartum stages.
However, the limitations associated with fetal & neonatal care equipment and chances of nosocomial infections, among others are some of the key constraints that may limit the growth of the fetal & neonatal care equipment market.
Fetal & Neonatal Care Equipment Market Segment Analysis:
Fetal & Neonatal Care Equipment Market by Product Type (Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others}), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the fetal & neonatal care equipment market, the ultrasound systems subcategory is estimated to account for a significant share in the fetal & neonatal care equipment market in 2024. This can be attributed to the various advantages and applications provided by the ultrasound devices. Ultrasound systems offer significant advantages and applications in fetal care, making them an indispensable tool for monitoring both fetal and maternal health throughout pregnancy. These systems provide real-time, dynamic imaging, enabling healthcare providers to visualize fetal development and movement, which is crucial for assessing fetal well-being.
Ultrasound technology serves a variety of essential purposes, including the detection of ectopic pregnancies, determination of gestational age, identification of congenital anomalies, evaluation of placental health, and monitoring of fetal position, growth, and amniotic fluid levels.
These systems also play a pivotal role in the assessment of developing fetal structures, such as the spine, hips, and brain, providing valuable insights into potential developmental concerns. Ultrasound is a standard practice during routine prenatal visits, with key applications in the first trimester for dating the pregnancy and confirming fetal viability, and in the second trimester for anomaly screening and growth assessment.
Additionally, the ability to assess fetal well-being and maternal health conditions with minimal invasiveness makes ultrasound a preferred diagnostic tool. The demand for ultrasound systems is further fueled by increasing product launches and regulatory approvals, which are enhancing the capabilities and accessibility of these devices.
For example, in November 2023, Siemens Healthineers launched the ACUSON Maple, a versatile and affordable ultrasound system that enhances diagnostic efficiency across various clinical settings. Equipped with machine learning, it automatically calculates fetal age and weight, reducing measurement time by up to 24% and enabling faster, more accurate assessments.
Similarly, Clarius Mobile Health received FDA clearance in June 2024 for its Clarius OB AI handheld ultrasound device, which automates fetal biometry measurements to estimate age, weight, and growth intervals, further advancing the capabilities of point-of-care fetal monitoring.
North America is expected to dominate the overall fetal & neonatal care equipment market:
North America is expected to dominate the fetal and neonatal care equipment market, holding the largest market share across all regions in 2024. This dominance can be attributed to several key factors, including the rising number of preterm births, the increasing prevalence of congenital anomalies, and the region's well-established, advanced healthcare infrastructure. Additionally, the ongoing technological innovations by leading industry players continue to drive the growth of the fetal and neonatal care equipment market in North America.
According to the data provided by the Centers for Disease Control and Prevention (CDC) in November 2024, preterm birth affected approximately 1 in 10 babies in the U.S. in 2022, amounting to nearly 380,000 premature births annually.
Additionally, the CDC reported in November 2024 that around 1 in every 33 babies, or approximately 120,000 infants annually, are born with congenital anomalies, highlighting the critical need for early detection and advanced care solutions. The country's robust healthcare system and access to cutting-edge medical technologies support the adoption of high-quality fetal and neonatal care equipment.
Leading companies are leveraging AI and other innovations to enhance diagnostic precision and efficiency. For example, in April 2024, GE HealthCare has introduced the Voluson Signature 20 and 18 ultrasound systems, which fully integrates artificial intelligence (AI) to enhance diagnostic capabilities. These systems leverage AI to automatically identify fetal anatomy in standard views, simplifying and accelerating fetal heart assessments by up to 48%. With AI-driven step-by-step guidance, they help healthcare providers quickly identify normal fetal heart anatomy, improving both efficiency and accuracy in prenatal care.
Moreover, in February 2023, Samsung introduced the HERA W10 Elite ultrasound system, capable of visualizing the fetal heart and brain as early as eight weeks through advanced endovaginal imaging.
Fetal & Neonatal Care Equipment Market Key Players:
Some of the key market players operating in the fetal and neonatal care equipment market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Getinge, Siemens Healthineers AG, Arjo, Masimo, VYAIRE, Hamilton Medical, Fisher & Paykel Healthcare Limited, Ibis Medical, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, SonoScape Medical Corp., MedGyn Products, Inc., Trivitron Healthcare, Nonin, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Pulsenmore Ltd., Ambu A/S, and others.
Recent Developmental Activities in the Fetal & Neonatal Care Equipment Market:
Key Takeaways from the Fetal & Neonatal Care Equipment Market Report Study
Target Audience who can be benefited from this Fetal & Neonatal Care Equipment Market Report Study
Frequently Asked Questions for the Fetal & Neonatal Care Equipment Market: